Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Fake vaccine concerns being put to bed as the Centre has shared a list of parameters based on their label, colour and other details to identify the authenticity of the Covid vaccines being used in the country. Reports indicate that the Modi&nbsp;Govt has shared various indicators with states to weed out any presence of spurious vaccine vials after WHO raised an alert for India and Africa.&ldquo;It was requested that the vaccines need to be carefully authenticated before use,&rdquo; the health ministry said in a letter to states.&nbsp;Here is how you can check if your vaccine vial is authentic -:Covishield, things to check-:

Genuine bottle will have a label shade of dark green&nbsp;
Trademark&nbsp;also mentioned on the original vaccine
Dark green aluminium flip-off seal
Font of the generic name is un-bold, (Recombinant)&nbsp;
CGS NOT FOR SALE. printed at the end of the generic name.
The SII logo is printed on the adhesive side of the label and at a unique angle
The entire label has been given a special honeycomb effect, which is visible only at a specific angle

Covaxin, things to check -:

Invisible UV DNA-like structure on the label which is only visible under UV light.
Micro text hidden in the label claims Dots, which is written as Covaxin
There is a green foil effect in X of Covaxin


Fake vaccine watch: Centre issues guidelines on how find out if your covid-19 vaccine is fake

How to spot a fake vaccine:&nbsp;Centre issues guidelines here are the markers you need to watch out for .&nbsp;

How to spot a fake vaccine

The Centre has shared a set of parameters to identify any fake Covid-19 vaccines with states after WHO reports alerting spurious batches.&nbsp;

Fake vaccine concerns being put to bed as the Centre has shared a list of parameters based on their label, colour and other details to identify the authenticity of the Covid vaccines being used in the country. Reports indicate that the Modi&nbsp;Govt has shared various indicators with states to weed out any presence of spurious vaccine vials after WHO raised an alert for India and Africa.&ldquo;It was requested that the vaccines need to be carefully authenticated before use,&rdquo; the health ministry said in a letter to states.&nbsp; Here is how you can check if your vaccine vial is authentic -: Covishield, things to check-:
<ul>
<li>Genuine bottle will have a label shade of dark green&nbsp;</li>
<li>Trademark&nbsp;also mentioned on the original vaccine</li>
<li>Dark green aluminium flip-off seal</li>
<li>Font of the generic name is un-bold, (Recombinant)&nbsp;</li>
<li>CGS NOT FOR SALE. printed at the end of the generic name.</li>
<li>The SII logo is printed on the adhesive side of the label and at a unique angle</li>
<li>The entire label has been given a special honeycomb effect, which is visible only at a specific angle</li>
</ul>
Covaxin, things to check -:
<ul>
<li>Invisible UV DNA-like structure on the label which is only visible under UV light.</li>
<li>Micro text hidden in the label claims Dots, which is written as Covaxin</li>
<li>There is a green foil effect in X of Covaxin</li>
</ul>

Israel to start human trials on Covid vaccine from Nov 1

The three stages of the human clinical trial of the Israeli vaccine&nbsp;involving over 30,000 volunteers are likely to last till mid-2021

Israel Institute for Biological Research&nbsp;will start human clinical trials of its Covid-19 vaccine candidate Brilife from November 1. The institute has got all necessary approvals from the Ministry of Health and the Helsinki Committee that&nbsp;deals with research approval and human experiments.&nbsp;The three stages of the human clinical trial involving over 30,000 volunteers are likely to last till mid-2021 and if all goes well, the vaccine could be ready for mass use only after that.&nbsp;The first phase of the human trial will include a series of safety tests with the participation of 80 healthy volunteers.

Jerusalem, PTI: Israel Institute for Biological Research (IIBR) will start human clinical trials of its Covid-19 vaccine candidate Brilife from November 1. The institute has got all necessary approvals from the Ministry of Health and the Helsinki Committee, the Israeli Defence Ministry said.
The Helsinki Committee deals with research approval and human experiments.
The committee is mandated to ensure the well being and rights of trial volunteers and to ensure that the experiment is conducted as per the approved medical guidelines and ethics, besides various domestic laws, rules and regulations.
The guidelines are outlined in the Declaration of Helsinki and various relevant international conventions.
The three stages of the human clinical trial involving over 30,000 volunteers are likely to last till mid-2021 and if all goes well, the vaccine could be ready for mass use only after that.
"This is a day of hope for the citizens of Israel, thanks to the IIBR researchers. Just two months ago I received the first bottle of the vaccine. Today we already have 25,000 vaccine doses and are starting the next phase of the test," said Alternate Prime Minister-cum-Defence Minister Benny Gantz.
"I would like to thank the dozens of researchers who work day and night on this national mission in full cooperation with the Ministry of Health. In this complex period, you are the 'commando unit' paving the way for the citizens of Israel. You took on a mission of international and historical importance," Gantz was quoted as saying in an official statement.
"The defence establishment, the Israeli government, and I will continue to provide you with the support and resources required to produce a safe and effective 'blue-and-white' vaccine," he stressed.
"Blue and White" refers to the colours in the Israeli flag, which also happens to be the name of the defence minister's party.
The first phase of the human trial will include a series of safety tests with the participation of 80 healthy volunteers (aged 18-55), designated by Sheba and Hadassah medical centres.
The trial will begin on November 1 with two participants initially. Depending on their responses, the vaccine will then be gradually administered to a total of 80 volunteers -- 40 in each medical centre.
Each volunteer will receive an injection and discharged after a few hours of observation. They will then be monitored over three weeks.

India's Covid-19 tally crosses 47 lakh-mark

India's Covid-19 case tally crossed the 47 lakh mark on Sunday with a spike of 94,372 new cases and 1,114 deaths reported in the last 24 hours. The total case tally stands at 47,54,357 including 9,73,175 active cases, and 37,02,596 people cured, according to data by the Ministry of Health. A total of 5,62,60,928 samples were tested up to 12th September. Of these, 10,71,702 samples were tested on Saturday, according to the Indian Council of Medical Research.

India's Covid&nbsp;tally crosses 47 lakh&nbsp;mark&nbsp; 94,372 cases, 1,114 deaths in 24 hours&nbsp; 37,02,596 people have recovered so far 5,62,60,928 samples tested up to Sept 12

India's Covid-19 case tally crossed the 47 lakh mark on Sunday with a spike of 94,372 new cases and 1,114 deaths reported in the last 24 hours. The total case tally stands at 47,54,357 including 9,73,175 active cases, and 37,02,596 people cured, according to data by the Ministry of Health. A total of 5,62,60,928 samples were tested up to 12th September. Of these, 10,71,702 samples were tested on Saturday, according to the Indian Council of Medical Research.

Cong calls it ‘anti-human’, says poor people are in danger; protest comes 2 days after state announces service tax in govt-run hospitals in district level and referral hospitals.

ministry of health

Categories